TNFi Unlikely to Raise Cancer Recurrence Risk in RA TNFi Unlikely to Raise Cancer Recurrence Risk in RA

Patients with rheumatoid arthritis who have had cancer can, in general, be treated with tumor necrosis factor inhibitors without increasing cancer recurrence risk, new data showed.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news